7,8-Dihydroxyflavone Enhanced Colonic Cholinergic Contraction and Relieved Loperamide-Induced Constipation in Rats

Dig Dis Sci. 2021 Dec;66(12):4251-4262. doi: 10.1007/s10620-020-06817-y. Epub 2021 Feb 2.

Abstract

Background: Whether 7,8-dihydroxyflavone (7,8-DHF), a tyrosine kinase receptor B (TrkB) agonist, modulates colonic smooth muscle motility and/or alleviates constipation has not yet been studied.

Aims: Here, we aimed to determine how 7,8-DHF influences carbachol (CCh)-stimulated contraction of colonic strips and the in vivo effect of 7,8-DHF on constipation.

Methods: Muscle strips were isolated from rat colons for recording contractile tension and performing western blotting. Constipation was induced in rats with loperamide.

Results: Although it specifically activated TrkB, 7,8-DHF applied alone neither activated PLCγ1 in the colonic strips nor induced colonic strip contraction. However, 7,8-DHF enhanced CCh-stimulated PLCγ1 activation and strip contraction. The PLCγ1 antagonist U73122 suppressed both CCh-stimulated and 7,8-DHF-enhanced/CCh-stimulated contraction. While clarifying the underlying mechanism, we revealed that 7,8-DHF augmented muscarinic M3 receptor expression in the colonic strips. The M3-selective antagonist tarafenacin specifically inhibited the 7,8-DHF-enhanced/CCh-stimulated contraction of the colonic strips. Since 7,8-DHF increased Akt phosphorylation, and LY294002 (an antagonist of PI3K upstream of Akt) dramatically inhibited both 7,8-DHF-augmented M3 expression and 7,8-DHF-enhanced/CCh-stimulated contractions, we assumed that 7,8-DHF/TrkB/Akt was associated with the modulation of M3 expression in the colonic strips. ANA-12, a specific TrkB antagonist, not only inhibited TrkB activation by 7,8-DHF but also suppressed 7,8-DHF-enhanced cholinergic contraction, 7,8-DHF/CCh-mediated activation of PLCγ1/Akt, and M3 overexpression in colonic strips. In vivo 7,8-DHF, also by promoting intestinal motility and M3 expression, significantly alleviated loperamide-induced functional constipation in rats.

Conclusions: Our results suggest that 7,8-DHF regulates colonic motility possibly via a TrkB/Akt/M3 pathway and may be applicable for alleviating constipation.

Keywords: 7,8-dihydroxyflavone; Colonic motility; Colonic strip; Constipation; Muscarinic M3 receptor.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Colon / drug effects*
  • Colon / metabolism
  • Colon / physiopathology
  • Constipation / chemically induced
  • Constipation / drug therapy*
  • Constipation / physiopathology
  • Defecation / drug effects*
  • Disease Models, Animal
  • Flavones / pharmacology*
  • Gastrointestinal Motility / drug effects*
  • In Vitro Techniques
  • Loperamide
  • Muscarinic Agonists / pharmacology*
  • Muscle Contraction / drug effects*
  • Muscle, Smooth / drug effects*
  • Muscle, Smooth / metabolism
  • Muscle, Smooth / physiopathology
  • Phospholipase C gamma / metabolism
  • Proto-Oncogene Proteins c-akt / metabolism
  • Receptor, Muscarinic M3 / agonists
  • Receptor, Muscarinic M3 / metabolism
  • Receptor, trkB / agonists
  • Receptor, trkB / metabolism
  • Signal Transduction

Substances

  • 6,7-dihydroxyflavone
  • Flavones
  • Muscarinic Agonists
  • Receptor, Muscarinic M3
  • Loperamide
  • Ntrk2 protein, rat
  • Receptor, trkB
  • Proto-Oncogene Proteins c-akt
  • Phospholipase C gamma
  • phospholipase Cgamma1, rat